New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
Emphasizing improved cardiac imaging workflow efficiency, Philips introduced the portable Compact Ultrasound 5500CV device at the recent American College of Cardiology (ACC) conference.
The company said the Compact Ultrasound 5500CV’s AI-driven Auto Measure function provides 50 percent faster two-dimensional and Doppler cardiac measurements.
The Compact Ultrasound 5500CV device provides 50 percent faster two-dimensional and Doppler cardiac measurements, according to Philips, the manufacturer of the device. (Image courtesy of Philips.)
Offering full compatibility with X7-2t and X8-2T transesophogeal echocardiography (TEE) transducers, the Compact Ultrasound 5500CV device facilitates high-resolution ultrasound images for catheter-based cardiac procedures, according to Philips. Employing mMatrix transducers, Philips pointed out the Compact Ultrasound 5500CV platform provides a significant advantage over two-dimensional ultrasound methods by enabling simultaneous capture of two cross-sectional views with a single probe pass.
“By bringing premium-level technology into a compact, accessible solution, we empower clinicians to deliver fast, accurate diagnoses across diverse care settings, improving patient outcomes and expanding access to advanced cardiac imaging,” noted David Handler, the business leader of cardiology ultrasound at Philips.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
